Home » Topics » Regulatory » Patents

Patents
RSS

Roche presents new metabotropic glutamate receptor ligands in the patent literature

April 6, 1999

Novel furansulfonic acid compounds for neurodegenerative, autoimmune and inflammatory disorders

April 6, 1999

Patent issued for new Merck glucagon antagonists

April 5, 1999

Therapeutically useful PDE4 inhibitors in development at ADIR

April 5, 1999

Inhibitors of the formation of AGTs described by Alteon

April 5, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

Multiple pharmacological effects reported by Egis for new AMPA receptor antagonists

March 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...